Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shengteng Shao"'
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundMalignant mesothelioma (MMe) is a rare and fatal cancer with a poor prognosis. Our study aimed to compare the overall survival (OS) of MMe patients across various sites and develop a prognostic model to provide a foundation for individualiz
Externí odkaz:
https://doaj.org/article/4de46278151844bc913d229e1581066b
Autor:
Shengteng Shao, Guisong Song, Yuanyong Wang, Tengfei Yi, Shuo Li, Fuhui Chen, Yang Li, Xiaotong Liu, Bin Han, Yuhong Liu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThis study aimed to conduct a comparative analysis of the survival rates after segmentectomy, wedge resection, or lobectomy in patients with cStage IA lung squamous cell carcinoma (SCC).MethodsWe enrolled 4,316 patients who had cStage IA lu
Externí odkaz:
https://doaj.org/article/697a47cebbeb40cca7661bcc600256fa
To investigate the clinical value of CTR, CEA, histological type, Ki-67 and EGFR in detecting pathological lymph node metastasis (pN) in clinical stage IA (cIA) lung adenocarcinoma and to construct a pN Nomogram model. A total of 374 cIA lung adenoca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e225539ad73f78fe0f383c8ef5dbdf72
https://doi.org/10.21203/rs.3.rs-405790/v1
https://doi.org/10.21203/rs.3.rs-405790/v1
Autor:
Shengteng Shao, Guisong Song, Yuanyong Wang, Tengfei Yi, Shuo Li, Fuhui Chen, Yang Li, Xiaotong Liu, Bin Han, Yuhong Liu
Publikováno v:
Frontiers in Oncology; 8/23/2022, Vol. 12, p1-12, 12p